Researchers have identified two compounds capable of repairing the protective myelin sheath damaged by multiple sclerosis, a major advance toward reversing nerve injury rather than just slowing it.

Zenas Biopharma has acquired global rights to develop BTK inhibitor orelabrutinib to treat progressive forms of multiple ...

Multiple sclerosis (MS) is a chronic autoimmune disease affecting more than 2.9 million people worldwide. It occurs when the ...

For decades, multiple sclerosis (MS) research has focused largely on the inflammatory lesions visible on MRI scans. Yet new ...

Vosheski has been at the helm for 21 years. For the last five years, he’s been battling MS. While he needs a scooter and ...

Resistance training is effective for improving gait speed in individuals with multiple sclerosis. The intensity and duration of resistance training are important factors in determining the magnitude ...

A noninvasive device that delivers weak electrical currents to the brain may help those with multiple sclerosis cut back on ...

A noninvasive device that delivers weak electrical currents to the brain may help those with multiple sclerosis cut back on ...

Actress Selma Blair talks through the daily rituals-dropping her son off at school, going horseback riding-that help her stay ...

A potentially $2 billion deal with InnoCare Pharma hands Zenas rights to a BTK inhibitor in late-stage testing for multiple ...

Roxy Murray, known as "The Multiple Sclerosis Fashionista," advocates for adaptive fashion that works both professionally and ...